Help protect patients at home & while traveling

Rabies, cholera, and typhoid fever represent public health threats in many countries around the world.^1,2,3

Help protect your patients during their travels.
Check to see which destinations could put them at risk.

Rabies RabAvert®
Cholera VAXCHORA®
Typhoid fever VIVOTIF®
Rabies + Cholera RabAvert and VAXCHORA
Rabies + Typhoid fever RabAvert and VIVOTIF
Cholera +Typhoid fever VAXCHORA and VIVOTIF
Rabies + Cholera + Typhoid fever RabAvert, VAXCHORA, and VIVOTIF

A world map highlighting countries where there is risk of rabies

A world map highlighting countries where there is risk of cholera

A world map highlighting countries where there is risk of typhoid fever

A world map highlighting countries where there is risk of rabies and cholera

A world map highlighting countries where there is risk of rabies and typhoid fever.

A world map highlighting countries where there is risk of cholera and typhoid fever

A world map highlighting countries where there is risk of rabies, cholera, and typhoid fever

Adapted from the Centers for Disease Control and Prevention and the World Health Organization.^1,2,3

Discover the Bavarian Nordic
vaccine portfolio

Rabies is fatal in almost 100% of cases, causing 70,000 deaths a year worldwide^*,1,5

*RabAvert is not indicated to treat the symptoms or consequences of rabies, such as death.

With 40 years of worldwide experience†^,4

RabAvert (Rabies Vaccine) is indicated for:⁶

Pre-exposure vaccination, in both primary series and booster doses against rabies in all age groups.
Post-exposure prophylaxis against rabies in all age groups.

†Comparative clinical significance unknown.

Help protect against rabies
with RabAvert.⁶

Learn more about RabAvert

There are 3–5 million cases of cholera each year, leading to 120,000 deaths worldwide^*,7

*VAXCHORA is not indicated to treat the symptoms or consequences of cholera, such as death.

The only one-dose cholera vaccine.†^,‡^,§,9

VAXCHORA (Cholera Vaccine, Live Attenuated, Oral) is indicated for the active immunization against diarrheal disease caused by Vibrio cholerae serogroup O1 in persons 2 to 64 years of age travelling to cholera-affected countries.⁸

†Comparative clinical significance unknown.
‡The duration of protection is unknown.
§The safety and effectiveness of revaccination with VAXCHORA vaccine have not been established. The effectiveness of VAXCHORA vaccine has not been established in persons who have pre-existing immunity due to previous exposure to V. cholerae or receipt of any prior cholera vaccine.

Help protect travellers
with VAXCHORA.⁸

Learn more about VAXCHORA

Typhoid fever affects 21 million people and causes 220,000 deaths globally each year^*,11

*VIVOTIF is not indicated to treat the symptoms or consequences of typhoid fever, such as death.

The only oral vaccine for typhoid fever.†^,10

VIVOTIF (Typhoid vaccine live oral attenuated Ty21a) is indicated for immunization of adults and children against disease caused by Salmonella typhi (new nomenclature: Salmonella enterica subspecies enterica serovar Typhi).¹²

†Comparative clinical significance unknown.

Help protect travellers against
typhoid fever with VIVOTIF.¹²

Learn more about VIVOTIF

Important safety information

Consult the RabAvert Product Monograph, VAXCHORA Product Monograph, or VIVOTIF Product Monograph for important information relating to adverse events, drug interactions, and dosing that has not been discussed in this piece. The Product Monograph is also available by calling 1-833-203-7933.

References: 1. Centers for Disease Control. Global rabies: what you should know. Available from: https://www.cdc.gov/rabies/around-world/index.html. Accessed July 8, 2025. 2. World Health Organization. Multi-country outbreak of cholera, external situation report #21–18 December 2024. World Health Organization; 2024 [cited 2025 Jul 7]. Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-cholera--external-situation-report--21---18-december-2024 . 3. Francois Watkins LK, Shih DC, Dorough L. Typhoid and paratyphoid fever [Internet]. Centers for Disease Control and Prevention; 2025 [cited 2025 Aug 13]. Available from: https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/typhoid-and-paratyphoid-fever.html .
4. Data on file. Bavarian Nordic A/S. September 23, 2025. 5. World Health Organization. Rabies: Key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/rabies . Accessed October 21, 2024. 6. RabAvert® (Rabies Vaccine) Product Monograph. Bavarian Nordic A/S. February 10, 2025. 7. Cholera and enterotoxigenic Escherichia coli (ETEC) travellers’ diarrhea vaccine: Canadian Immunization Guide [Internet]; 2024 [cited 2025 Jan 8]. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-3-cholera-enterotoxigenic-escherichia-coli-travellers-diarrhea-vaccine.html. 8. VAXCHORA® Product Monograph. Bavarian Nordic A/S. January 9, 2024. 9. Data on file. Bavarian Nordic A/S. December 4, 2024. 10. Data on file. Bavarian Nordic A/S. September 10, 2025. 11. Government of Canada. Typhoid vaccines: Canadian Immunization Guide. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-23-typhoid-vaccine.html . Accessed July 8, 2025. 12. VIVOTIF® Product Monograph. Bavarian Nordic A/S. December 27, 2023.

Allow	Category	Purpose	Tools
Yes No	Functional	To monitor the performance of our site and to enhance your browsing experience. For example, these tools enable you to communicate with us via live chat.
Yes No	Marketing and Analytics	To understand user behaviour in order to provide you with a more relevant browsing experience or personalize the content on our site. For example, we collect information about which pages you visit to help us present more relevant information.	Google Analytics
Yes No	Advertising	To personalize and measure the effectiveness of advertising on our site and other websites. For example, we may serve you a personalized ad based on the pages you visit on our site.	Facebook Pixel, Google Tag Manager
N/A	Essential	We use browser cookies that are necessary for the site to work as intended. For example, we store your website data collection preferences so we can honour them if you return to our site. You can disable these cookies in your browser settings but if you do the site may not work as intended.

Travelling can expose patients to vaccine-preventable diseases1,2,3

Rabies, cholera, and typhoid fever represent public health threats in many countries around the world.1,2,3

Help protect your patients during their travels. Check to see which destinations could put them at risk.

Discover the Bavarian Nordic vaccine portfolio

Rabies is fatal in almost 100% of cases, causing 70,000 deaths a year worldwide*,1,5

With 40 years of worldwide experience†,4

There are 3–5 million cases of cholera each year, leading to 120,000 deaths worldwide*,7

The only one-dose cholera vaccine.†,‡,§,9

Typhoid fever affects 21 million people and causes 220,000 deaths globally each year*,11

The only oral vaccine for typhoid fever.†,10